Bipartisan Health Care Act

Makes wide-ranging health-care changes: it reforms pharmacy benefit manager (PBM) practices and drug-payment transparency, updates Medicaid hospital DSH payment rules, extends and adjusts Medicare telehealth and new multi-cancer screening payment rules, reauthorizes and funds many public‑health and human‑services programs, creates a federal wastewater surveillance grant program, strengthens FDA pediatric and rare‑disease provisions, and preserves a short HDHP safe harbor for telehealth. Many provisions impose new reporting, pricing, and payment requirements and phase in over months to years.

The bill combines program authorizations and regulatory reforms that affect hospitals, pharmacies, PBMs, health plans, Medicare and Medicaid beneficiaries, public‑health grantees, drug developers, and state health agencies. It includes new funding authorizations for community health centers and other public‑health programs, deadlines for agency guidance, and a mix of near‑term and delayed effective dates (6–30 months or specified through 2026–2029 for some items).